Cited by 455Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanismsTraumatic Brain Injury and Neurovascular Disturbances

Absence of Glial Fibrillary Acidic Protein and Vimentin Prevents Hypertrophy of Astrocytic Processes and Improves Post-Traumatic Regeneration

Open access
Wilhelmsson, Ulrika, Li, Lizhen, Pekna, Marcela, Berthold, Claes-Henric, Blom, Sofia, Eliasson, Camilla, Renner, Oliver, Bushong, Eric +3 more·2004·The Journal of Neuroscience

Abstract

The regenerative capacity of the CNS is extremely limited. The reason for this is unclear, but glial cell involvement has been suspected, and oligodendrocytes have been implicated as inhibitors of neuroregeneration (Chen et al., 2000, GrandPre et al., 2000; Fournier et al., 2001). The role of astrocytes in this process was proposed but remains incompletely understood (Silver and Miller, 2004). Astrocyte activation (reactive gliosis) accompanies neurotrauma, stroke, neurodegenerative diseases, or tumors. Two prominent hallmarks of reactive gliosis are hypertrophy of astrocytic processes and upregulation of intermediate filaments. Using the entorhinal cortex lesion model in mice, we found that reactive astrocytes devoid of the intermediate filament proteins glial fibrillary acidic protein and vimentin (GFAP-/-Vim-/-), and consequently lacking intermediate filaments (Colucci-Guyon et al., 1994; Pekny et al., 1995; Eliasson et al., 1999), showed only a limited hypertrophy of cell processes. Instead, many processes were shorter and not straight, albeit the volume of neuropil reached by a single astrocyte was the same as in wild-type mice. This was accompanied by remarkable synaptic regeneration in the hippocampus. On a molecular level,GFAP-/-Vim-/-reactive astrocytes could not upregulate endothelin B receptors, suggesting that the upregulation is intermediate filament dependent. These findings show a novel role for intermediate filaments in astrocytes and implicate reactive astrocytes as potent inhibitors of neuroregeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.0820-04.2004

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Under baseline conditions, Gfap−/−Vim−/− mice have astrocytes of normal appearance and grossly normal brain anatomy.

    “Under baseline conditions, however, Gfap−/−Vim−/− mice have astrocytes of normal appearance and grossly normal brain anatomy (22, 23, 32).”

    From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [23]

    Figure 1 and the Results (page not specified in our copy) report similar astrocyte morphology and process length in GFAP−/− Vim−/− and wild-type mice before lesion. The paper does not establish the broader claim that their brain anatomy is grossly normal. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • GFAP and Vim are expressed at high levels in activated astrocytes and are critical for the activated phenotype.

    “The intermediate filament proteins GFAP and Vim are expressed at high levels in activated astrocytes and are critical for the activated phenotype.”

    From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [23]

    The Introduction describes intermediate-filament upregulation as a hallmark of reactive astrocytes and proposes that it is crucial to activation. Figure 1 and the Results show that loss of GFAP and vimentin prevents process hypertrophy and endothelin B receptor upregulation after injury. The paper still calls the deficient astrocytes reactive, so it supports a role in specific features of the activated phenotype, not that these proteins are critical to the activated phenotype as a whole. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • When Gfap and Vim are both deleted, astrocytes cannot form intermediate filament networks or display reactive morphology.

    “But when Gfap and Vim are both deleted, astrocytes cannot form intermediate filament networks or display reactive morphology (22, 23, 32).”

    From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [23]

    The Introduction says GFAP/Vim-deficient astrocytes are completely devoid of intermediate filaments. But the Results and Figure 1 describe them as reactive astrocytes with altered morphology and limited process hypertrophy, not as unable to display any reactive morphology. Page numbers are not available in the supplied copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Astrocytes of Gfap−/−Vim−/− mice in the injured area do not develop the characteristic hypertrophy of proximal processes.

    “On a cellular level, astrocytes of Gfap−/−Vim−/− mice in the injured area do not develop the characteristic hypertrophy of proximal processes (23).”
  • Gfap−/−Vim−/− mice exhibit better posttraumatic regeneration of neuronal synapses and axons, increased baseline and posttraumatic neurogenesis, and improved functional recovery after spinal cord trauma.

    “Interestingly, Gfap−/−Vim−/− mice exhibit better posttraumatic regeneration of neuronal synapses (23) and axons (34), increased baseline and posttraumatic neurogenesis (35), and improved functional recovery after spinal cord trauma (36).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wilhelmsson, U., Li, L., Pekna, M., Berthold, C.-H., Blom, S., Eliasson, C., Renner, O., Bushong, E., Ellisman, M., Morgan, T. E., & Pekny, M.
Affiliations
  • University of Gothenburg (SE)
  • Spanish National Cancer Research Centre (ES)
  • University of California San Diego (US)
  • University of Southern California (US)
Venue
The Journal of Neuroscience
Published
2004-05-26
Volume
24
Issue
21
Pages
5016-5021
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2166851454
Cited by
455
References
126
Citations by year
2026: 14 · 2025: 13 · 2024: 14 · 2023: 12 · 2022: 24 · 2021: 23 · 2020: 31 · 2019: 22 · 2018: 15 · 2017: 18 · 2016: 15 · 2015: 24 · 2014: 26 · 2013: 27 · 2012: 36
FWCI
14.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Gothenburg University Publications Electronic Archive (Gothenburg University) (submittedVersion)
Funders
  • Alzheimer's Association
  • Swedish Cancer Foundation
  • Svenska Sällskapet för Medicinsk Forskning
  • Vetenskapsrådet
  • National Institutes of Health (RR 04050)
  • National Center for Research Resources (RR 04050, P41RR004050, P41 RR04050)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
glial fibrillary acidic protein, vimentin, intermediate filaments, reactive astrocytes, astrocyte hypertrophy, astrocytic processes, nerve regeneration, entorhinal cortex lesion, endothelin B receptor, synaptic regeneration, hippocampus
MeSH terms
Animals, Astrocytes, Brain Injuries, Cells, Cultured, Cytoplasm, Glial Fibrillary Acidic Protein, Glutamate-Ammonia Ligase, Hippocampus, Hypertrophy, Mice, Inbred C57BL, Nerve Regeneration, Vimentin, Up-Regulation, Entorhinal Cortex, Receptor, Endothelin B, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review